Atlas Trials

Randomized, Double Blind, Placebo-controlled Phase 2 Study in Adults With Celiac Disease

Clinical trial NCT06982963 · RECRUITING

Trial details

NCT number
NCT06982963
Sponsor
Forte Biosciences, Inc.
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Celiac Disease
Start date
2025-08-04
Primary completion
2027-02-28
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.